Anavex Life Sciences Corp. (AVXL) stock
Close on Nov 17, 2026Market cap $68.60MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $68.60M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.61
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$13.02M
- EPS, diluted
- -$0.15
- Book value per share
- $0.00
- Diluted shares
- 92.90B
Trading
- Next earnings
- Nov 24, 2026 (estimated, before the open)
- Previous close
- $0.82
- Open
- $0.83
- Day's range
- $0.71 – $0.84
- Volume
- 2,272,004
- Average volume (20 days)
- 1,181,518
- Index membership
- Russell 2000, Russell 3000 (since Nov 2019)
- 52-week range
- $0.71 – $5.36
- RSI (14 days)
- 20.3
- Volatility (1 year)
- 83.1%
- Relative volume
- 2.15×
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.
| Period | AVXL | S&P 500 | Difference | AVXL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -43.5% | -4.0% | −39.5 pts | ||
| 3 months | -76.9% | -5.0% | −72.0 pts | ||
| Year to date | -79.2% | +8.2% | −87.5 pts | ||
| 1 year | -79.3% | +11.2% | −90.5 pts | ||
| 3 years | -88.2% | +68.5% | −156.7 pts | -50.9% | +19.0% |
| 5 years | -96.5% | +67.3% | −163.7 pts | -48.8% | +10.8% |
| 10 years | -76.9% | +291.6% | −368.5 pts | -13.6% | +14.6% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Anavex Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- Results
- Update
- Update
About Anavex Life Sciences
Biological Products, (No Diagnostic Substances)
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company that develops therapeutics for central nervous system disorders. The company applies precision medicine and analyzes genomic data from clinical trials to identify biomarkers that guide treatment assessment. Its core research pipeline focuses on compounds that target sigma-1 receptor activation to restore cellular homeostasis. Key product candidates include ANAVEX 2-73, also known as blarcamesine, which is evaluated in oral capsule and liquid formulations, and ANAVEX 3-71. These therapies target conditions such as Alzheimer's disease, Parkinson's disease, and Rett syndrome.
Company profile, executives and historyAnavex Life Sciences stock: common questions
What is Anavex Life Sciences's stock price?
AVXL closed at $0.74 on Nov 17, 2026, down 9.49% on the day. Over the past 52 weeks it traded between $0.71 and $5.36.
What is Anavex Life Sciences's market cap?
Anavex Life Sciences was worth $68.60M at the close on Nov 17, 2026: the share price times the diluted shares outstanding.
What is AVXL's P/E ratio?
Anavex Life Sciences lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.15), so it has no meaningful P/E ratio.
Does Anavex Life Sciences pay a dividend?
No. Anavex Life Sciences has not paid a cash dividend over the last twelve months.
When does Anavex Life Sciences report earnings next?
Anavex Life Sciences is expected to report Q4 FY2026 results on Nov 24, 2026, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has AVXL stock performed over the past year?
Including dividends, AVXL returned -79.3% over the past year, against +11.2% for the S&P 500.
How many AVXL shares are sold short?
12M shares were sold short at the latest FINRA report, 13.29% of the float, or 10.1 days of average trading volume.
Who are Anavex Life Sciences's competitors?
Companies most similar to Anavex Life Sciences by business, industry and size include NMRA, ALEC, CGTX, TSHA, PASG.
See a number that looks wrong?